Материал: Нормальная+беременность

76.Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Metaanalysis. JAMA. 2019;322(7):632–41.

77.Stettler RW, Cunningham FG. Natural history of chronic proteinuria complicating pregnancy. Am J Obstet Gynecol. 1992 Nov;167(5):1219–24.

78.Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ. 2012 Jul;345:e4342.

79.Sanchez-Ramos L, Gillen G, Zamora J, Stenyakina A, Kaunitz AM. The protein-to-creatinine ratio for the prediction of significant proteinuria in patients at risk for preeclampsia: a metaanalysis. Ann Clin Lab Sci. 2013;43(2):211–20.

80.Thangaratinam S, Coomarasamy A, O’Mahony F, Sharp S, Zamora J, Khan KS, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC Med. 2009 Mar;7:10.

81.Meggiolaro A, Unim B, Semyonov L, Miccoli S, Maffongelli E, La Torre G. The role of Pap test screening against cervical cancer: a systematic review and meta-analysis. Clin Ter. 167(4):124–39.

82.Rozenberg P. [Is there a role for X-ray pelvimetry in the twenty-first century?]. Gynecol Obstet Fertil. 2007 Jan;35(1):6–12.

83.Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, et al. First and second trimester serum tests with and without first trimester ultrasound tests for Down’s syndrome screening. Cochrane database Syst Rev. 2017 Mar 15;3:CD012599.

84.Whitworth M, Bricker L, Mullan C. Ultrasound for fetal assessment in early pregnancy. Cochrane database Syst Rev. 2015 Jul 14;(7):CD007058.

85.Edwards L, Hui L. First and second trimester screening for fetal structural anomalies. Semin Fetal Neonatal Med. 2018;23(2):102–11.

86.Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005 Nov 10;353(19):2001–11.

87.Policy. Perinatal Practice Guideline Cervical Insufficiency and Cerclage. SA Maternal, Neonatal & Gynaecology Community of Practice 14 November 2017.

88.Maruotti GM, Saccone G, Martinelli P. Third trimester ultrasound soft-tissue measurements accurately predicts macrosomia. J Matern Fetal Neonatal Med. 2017 Apr;30(8):972–6.

89.Caradeux J, Martinez-Portilla RJ, Peguero A, Sotiriadis A, Figueras F. Diagnostic performance of third-trimester ultrasound for the prediction of late-onset fetal growth restriction: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019 Jan 8;

90.Sentilhes L., Sénat M.V., Ancel PY, Azria E. BG et al. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obs Gynecol Reprod Biol. 2017;(210):217–224.

91.Dunn L, Sherrell H, Kumar S. Review: Systematic review of the utility of the fetal cerebroplacental ratio measured at term for the prediction of adverse perinatal outcome. Placenta. 2017;54:68–75.

92.Vollgraff Heidweiller-Schreurs CA, De Boer MA, Heymans MW, Schoonmade LJ, Bossuyt PMM, Mol BWJ, et al. Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018 Mar;51(3):313–22.

93.Nassr AA, Abdelmagied AM, Shazly SAM. Fetal cerebro-placental ratio and adverse perinatal outcome: systematic review and meta-analysis of the association and diagnostic performance. J

Perinat Med. 2016 Mar;44(2):249–56.

94.Alfirevic Z, Stampalija T, Dowswell T. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane database Syst Rev. 2017;6:CD007529.

95.Alfirevic Z, Stampalija T, Medley N. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane database Syst Rev. 2015 Apr 15;(4):CD001450.

96.Grivell RM, Alfirevic Z, Gyte GML, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane database Syst Rev. 2015 Sep 12;(9):CD007863.

97.Жангереев АТ. Роль санитарно-просветительной работы в профилактике кариеса зубов и гигиены полости рта у беременных. Клиническая медицина Казахстана. 2012;2(25).

98.Арабаджян СИ, Д.В. А, Полунина ЕГ, Казарян ЭЭ, Щеголева ИВ. Роль офтальмологического обследования при беременности. Уральский медицинский журнал. 2018;(1):108–11.

99.Кречмар МВ. Особенности пренатального медико-генетического консультирования. Журнал акушерства и женских болезней. 2007;56(1).

100.Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017 Sep;50(3):302–14.

101.García-Pérez L, Linertová R, Álvarez-de-la-Rosa M, Bayón JC, Imaz-Iglesia I, Ferrer-Rodríguez J, et al. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review. Eur J Health Econ. 2018 Sep;19(7):979–91.

102.Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane database Syst Rev. 2017;9:CD003252.

103.Beta J, Lesmes-Heredia C, Bedetti C, Akolekar R. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecol. 2018 Apr;70(2):215–9.

104.Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015 Jan;45(1):16–26.

105.Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane database Syst Rev. 2015 Sep 8;(9):CD007575.

106.Aikins Murphy P. Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol. 1998 Jan;91(1):149–55.

107.Keating A, Chez RA. Ginger syrup as an antiemetic in early pregnancy. Altern Ther Health Med. 8(5):89–91.

108.Jewell DJ, Young G. Interventions for treating constipation in pregnancy. Cochrane database Syst Rev. 2001;(2):CD001142.

109.Thaler E, Huch R, Huch A, Zimmermann R. Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study. Swiss Med Wkly. 2001 Dec 1;131(45–46):659–62.

110.Pennick V, Liddle SD. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane database Syst Rev. 2013 Aug 1;(8):CD001139.

111.Liddle SD, Pennick V. Interventions for preventing and treating low-back and pelvic pain during pregnancy. Cochrane database Syst Rev. 2015 Sep 30;(9):CD001139.

112.Fry D, Hay-Smith J, Hough J, McIntosh J, Polden M, Shepherd J, et al. National clinical guidelines for the care of women with symphysis pubis dysfunction. Association of Chartered Physiotherapists in Women’s Health. Midwives. 1997 Jul;110(1314):172–3.

113.Shaw RW. Randomized controlled trial of Syn-Ergel and an active placebo in the treatment of heartburn of pregnancy. J Int Med Res. 1978;6(2):147–51.

114.Lang GD, Dougall A. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy. Br J Clin Pract Suppl. 1989 Feb;66:48– 51; discussion 61-4.

115.Wijayanegara H, Mose JC, Achmad L, Sobarna R, Permadi W. A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy. J Int Med Res. 1992 Feb;20(1):54–60.

116.Buckshee K, Takkar D, Aggarwal N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet. 1997 May;57(2):145–51.

117.Villar J, Lydon-Rochelle MT, Gülmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane database Syst Rev. 2000;(2):CD000491.

118.Li Z, Gindler J, Wang H, Berry RJ, Li S, Correa A, et al. Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. Lancet (London, England). 2003 Feb 1;361(9355):380–4.

119.De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane database Syst Rev. 2015 Dec;(12):CD007950.

120.Public Health Committee of the American Thyroid Association, Becker D V, Braverman LE, Delange F, Dunn JT, Franklyn JA, et al. Iodine supplementation for pregnancy and lactation-United States and Canada: recommendations of the American Thyroid Association. Thyroid. 2006 Oct;16(10):949–51.

121.Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315–89.

122.Harding KB, Peña-Rosas JP, Webster AC, Yap CM, Payne BA, Ota E, et al. Iodine supplementation for women during the preconception, pregnancy and postpartum period. Cochrane database Syst Rev. 2017;3:CD011761.

123.Committee Opinion No. 638: First-Trimester Risk Assessment for Early-Onset Preeclampsia. Obstet Gynecol. 2015 Sep;126(3):e25-7.

124.Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 May;160(10):695–703.

125.Hofmeyr GJ, Lawrie TA, Atallah ÁN, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane database Syst Rev. 2018;10:CD001059.

126.Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O’Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013 Mar 26;346:f1169.

127.Wei S-Q, Qi H-P, Luo Z-C, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013 Jun;26(9):889–99.

128.Dunnigan MG, Henderson JB, Hole DJ, Barbara Mawer E, Berry JL. Meat consumption reduces the risk of nutritional rickets and osteomalacia. Br J Nutr. 2005 Dec;94(6):983–91.

129.Finch PJ, Ang L, Colston KW, Nisbet J, Maxwell JD. Blunted seasonal variation in serum 25hydroxy vitamin D and increased risk of osteomalacia in vegetarian London Asians. Eur J Clin Nutr. 1992 Jul;46(7):509–15.

130.Roth DE, Morris SK, Zlotkin S, Gernand AD, Ahmed T, Shanta SS, et al. Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. N Engl J Med. 2018 Aug

9;379(6):535–46.

131.Sammour MB, El-Kabarity H, Fawzy MM, Schindler AE. WHO Recommendations for prevention and treatment of pre-eclampsia and eclampsia. Vol. 97, WHO Recommendations for Prevention and Treatment of Pre-Eclampsia and Eclampsia. 2011. 439–440 p.

132.Wolf HT, Hegaard HK, Huusom LD, Pinborg AB. Multivitamin use and adverse birth outcomes in high-income countries: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(4):404.e1-404.e30.

133.Saccone G, Saccone I, Berghella V. Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence? J Matern Fetal Neonatal Med. 2016;29(15):2389–97.

134.Kuper SG, Abramovici AR, Jauk VC, Harper LM, Biggio JR, Tita AT. The effect of omega-3 supplementation on pregnancy outcomes by smoking status. Am J Obstet Gynecol. 2017;217(4):476.e1-476.e6.

135.Hemminki E, Rimpelä U. A randomized comparison of routine versus selective iron supplementation during pregnancy. J Am Coll Nutr. 1991 Feb;10(1):3–10.

136.British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. London; 439–440 p.

137.Dolk HM, Nau H, Hummler H, Barlow SM. Dietary vitamin A and teratogenic risk: European Teratology Society discussion paper. Eur J Obstet Gynecol Reprod Biol. 1999 Mar;83(1):31–6.

138.Rumbold A, Ota E, Hori H, Miyazaki C, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane database Syst Rev. 2015 Sep 7;(9):CD004069.

139.Rumbold A, Ota E, Nagata C, Shahrook S, Crowther CA. Vitamin C supplementation in pregnancy. Cochrane database Syst Rev. 2015 Sep 29;(9):CD004072.

140.Siega-Riz AM, Adair LS, Hobel CJ. Institute of Medicine maternal weight gain recommendations and pregnancy outcome in a predominantly Hispanic population. Obstet Gynecol. 1994 Oct;84(4):565–73.

141.Abrams B, Altman SL, Pickett KE. Pregnancy weight gain: still controversial. Am J Clin Nutr. 2000;71(5 Suppl):1233S-41S.

142.Tian C, Hu C, He X, Zhu M, Qin F, Liu Y, et al. Excessive weight gain during pregnancy and risk of macrosomia: a meta-analysis. Arch Gynecol Obstet. 2016 Jan;293(1):29–35.

143.Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al. Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Metaanalysis. JAMA. 2017 Jun 6;317(21):2207–25.

144.Johansson K, Hutcheon JA, Bodnar LM, Cnattingius S, Stephansson O. Pregnancy weight gain by gestational age and stillbirth: a population-based cohort study. BJOG. 2018 Jul;125(8):973–81.

145.Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy outcome: a meta-analysis. Obstet Gynecol. 2000 Apr;95(4):623–35.

146.Jurewicz J, Hanke W, Makowiec-Dabrowska T, Kalinka J. [Heaviness of the work measured by energy expenditure during pregnancy and its effect on birth weight]. Ginekol Pol. 2006 Jul;77(7):537–42.

147.Hanke W, Saurel-Cubizolles MJ, Sobala W, Kalinka J. Employment status of pregnant women in central Poland and the risk of preterm delivery and small-for-gestational-age infants. Eur J Public Health. 2001 Mar;11(1):23–8.

148.Roman E, Doyle P, Ansell P, Bull D, Beral V. Health of children born to medical radiographers. Occup Environ Med. 1996 Feb;53(2):73–9.

149.Chavarro JE, Rich-Edwards JW, Gaskins AJ, Farland L V, Terry KL, Zhang C, et al. Contributions of the Nurses’ Health Studies to Reproductive Health Research. Am J Public Health. 2016 Sep;106(9):1669–76.

150.ACOG Committee Opinion No. 650: Physical Activity and Exercise During Pregnancy and the Postpartum Period. Obstet Gynecol. 2015 Dec;126(6):e135-42.

151.Clapp JF, Simonian S, Lopez B, Appleby-Wineberg S, Harcar-Sevcik R. The one-year morphometric and neurodevelopmental outcome of the offspring of women who continued to exercise regularly throughout pregnancy. Am J Obstet Gynecol. 1998 Mar;178(3):594–9.

152.Kramer MS, McDonald SW. Aerobic exercise for women during pregnancy. Cochrane database Syst Rev. 2006 Jul;(3):CD000180.

153.Camporesi EM. Diving and pregnancy. Semin Perinatol. 1996 Aug;20(4):292–302.

154.Read JS, Klebanoff MA. Sexual intercourse during pregnancy and preterm delivery: effects of vaginal microorganisms. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1993 Feb;168(2):514–9.

155.Klebanoff MA, Nugent RP, Rhoads GG. Coitus during pregnancy: is it safe? Lancet (London, England). 1984 Oct;2(8408):914–7.

156.Berghella V, Klebanoff M, McPherson C, Carey JC, Hauth JC, Ernest JM, et al. Sexual intercourse association with asymptomatic bacterial vaginosis and Trichomonas vaginalis treatment in relationship to preterm birth. Am J Obstet Gynecol. 2002 Nov;187(5):1277–82.

157.Royal College of Obstetricians and Gynaecologists. Advice on preventing deep vein thrombosis for pregnant women travelling by air. Scientific Advisory Committee Opinion paper No. 1. London: RCOG. 2001;

158.ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 443: Air travel during pregnancy. Obstet Gynecol. 2009 Oct;114(4):954–5.

159.Scurr JH, Machin SJ, Bailey-King S, Mackie IJ, McDonald S, Smith PD. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet (London, England). 2001 May;357(9267):1485–9.

160.Clarke M, Hopewell S, Juszczak E, Eisinga A, Kjeldstrøm M. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane database Syst Rev. 2006 Apr; (2):CD004002.

161.Klinich KD, Schneider LW, Moore JL, Pearlman MD. Investigations of crashes involving pregnant occupants. Annu proceedings Assoc Adv Automot Med. 2000;44:37–55.

162.Crosby WM, Costiloe JP. Safety of lap-belt restraint for pregnant victims of automobile collisions. N Engl J Med. 1971 Mar;284(12):632–6.

163.Lewis G, Drife J E. Why mothers die 1997–1999: The fifth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. RCOG Press; 2001.

164.Arroyo V, Linares C, Díaz J. Premature births in Spain: Measuring the impact of air pollution using time series analyses. Sci Total Environ. 2019 Apr;660:105–14.

165.Pedersen M, Stayner L, Slama R, Sørensen M, Figueras F, Nieuwenhuijsen MJ, et al. Ambient air pollution and pregnancy-induced hypertensive disorders: a systematic review and metaanalysis. Hypertens (Dallas, Tex 1979). 2014 Sep;64(3):494–500.

166.Quansah R, Armah FA, Essumang DK, Luginaah I, Clarke E, Marfoh K, et al. Association of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysis. Environ Health Perspect. 2015 May;123(5):412–21.

167.Pergialiotis V, Kotrogianni P, Christopoulos-Timogiannakis E, Koutaki D, Daskalakis G, Papantoniou N. Bisphenol A and adverse pregnancy outcomes: a systematic review of the literature. J Matern Fetal Neonatal Med. 2018;31(24):3320–7.

168.Committee on Obstetric Practice. Committee opinion No. 533: lead screening during pregnancy and lactation. Obstet Gynecol. 2012 Aug;120(2 Pt 1):416–20.

169.Carmona R, Gerberding J. The Health Consequences of Smoking: A Report of the Surgeon General (28th Edition). ed. Health and Human Services Dept., Public Health Service, Office of the